Lockdown across the country to curb the spread of coronavirus is resulting in drugs and medical devices not reaching the hospitals and consumers despite them being exempted by the government, industry players said on Wednesday.
Avoidable restrictions have been imposed by local police on the mobility of the citizens associated with the supply, distributions and transport of medicines, raw materials, components to make masks, sanitizers and other medical devices to the factories and manufacturing plants which are holding up production, adding to shortage, AiMeD Forum Coordinator Rajiv Nath said in a statement.
Pharmaceutical and medical device manufacturers are also facing issues as some of the district administrations in various states/ UTs have incorrectly given directions to close the manufacturing operations in the pharmaceutical and medical device industry also as part of various measures to contain the spread of coronavirus, AiMeD said.
"We on behalf of the Indian Medical Device Industry appeal to local administration and police to recognise that medicines, raw materials, components to make masks, sanitizers and other medical devices like gloves, consumables, disposables, electronics, equipments, instruments, implants and IVD reagents are most essential healthcare delivery products at this critical hour of crisis," Nath said.
So, the authorities are requested to extend support and give free passage to the people in the supply chain of essential commodities to reach factories, manufacturing plants, among others, he added.
In this regard, the Department of Pharmaceuticals (DoP) has written to the chief secretaries of all state/ UTs to review the matter and issue directions for treating these activities as essential services and also direct the authorities concerned to make necessary arrangements for issuance IDs/ entry pass so as to facilitate movements of the workers engaged in these essential activities.
"Further, in cases where inter-state movements of workers are involved, you may sort the matter with your counterpart in the state concerned, so that the pharma/ medical devices factories function without any hindrance," the letter said.
In similar vein, in a regulatory filing, Suven Pharmaceuticals said, "Even though pharma manufacturing is exempted from this lockdown situation, there are many obstacles which we are encountering, namely no movement of goods interstate nor intrastate."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
